Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Sep 3;93(18):9748–9753. doi: 10.1073/pnas.93.18.9748

Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme.

I Halpert 1, U I Sires 1, J D Roby 1, S Potter-Perigo 1, T N Wight 1, S D Shapiro 1, H G Welgus 1, S A Wickline 1, W C Parks 1
PMCID: PMC38500  PMID: 8790402

Abstract

Certain matrix metalloproteinases (MMP) are expressed within the fibrous areas surrounding acellular lipid cores of atherosclerotic plaques, suggesting that these proteinases degrade matrix proteins within these areas and weaken the structural integrity of the lesion. We report that matrilysin and macrophage metalloelastase, two broad-acting MMPs, were expressed in human atherosclerotic lesions in carotid endarterectomy samples (n = 18) but were not expressed in normal arteries (n = 7). In situ hybridization and immunohistochemistry revealed prominent expression of matrilysin in cells confined to the border between acellular lipid cores and overlying fibrous areas, a distribution distinct from other MMPs found in similar lesions. Metalloelastase was expressed in these same border areas. Matrilysin was present in lipid-laden macrophages, identified by staining with anti-CD-68 antibody. Furthermore, endarterectomy tissue in organ culture released matrilysin. Staining for versican demonstrated that this vascular proteoglycan was present at sites of matrilysin expression. Biochemical studies showed that matrilysin degraded versican much more efficiently than other MMPs present in atherosclerotic lesions. Our findings suggest that matrilysin, specifically expressed in atherosclerotic lesions, could cleave structural proteoglycans and other matrix components, potentially leading to separation of caps and shoulders from lipid cores.

Full text

PDF
9748

Images in this article

9749Fig. 1
on p.9749
9750Fig. 2
on p.9750
9751Fig. 3
on p.9751
9752Fig. 4
on p.9752
9752Fig. 5
on p.9752

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baragi V. M., Fliszar C. J., Conroy M. C., Ye Q. Z., Shipley J. M., Welgus H. G. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J Biol Chem. 1994 Apr 29;269(17):12692–12697. [PubMed] [Google Scholar]
  2. Birkedal-Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., Engler J. A. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4(2):197–250. doi: 10.1177/10454411930040020401. [DOI] [PubMed] [Google Scholar]
  3. Brown D. L., Hibbs M. S., Kearney M., Loushin C., Isner J. M. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation. 1995 Apr 15;91(8):2125–2131. doi: 10.1161/01.cir.91.8.2125. [DOI] [PubMed] [Google Scholar]
  4. Busiek D. F., Baragi V., Nehring L. C., Parks W. C., Welgus H. G. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol. 1995 Jun 15;154(12):6484–6491. [PubMed] [Google Scholar]
  5. Busiek D. F., Ross F. P., McDonnell S., Murphy G., Matrisian L. M., Welgus H. G. The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem. 1992 May 5;267(13):9087–9092. [PubMed] [Google Scholar]
  6. Davies M. J., Thomas A. C. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985 Apr;53(4):363–373. doi: 10.1136/hrt.53.4.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983 Aug;50(2):127–134. doi: 10.1136/hrt.50.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gaire M., Magbanua Z., McDonnell S., McNeil L., Lovett D. H., Matrisian L. M. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem. 1994 Jan 21;269(3):2032–2040. [PubMed] [Google Scholar]
  9. Galis Z. S., Sukhova G. K., Lark M. W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994 Dec;94(6):2493–2503. doi: 10.1172/JCI117619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henney A. M., Wakeley P. R., Davies M. J., Foster K., Hembry R., Murphy G., Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8154–8158. doi: 10.1073/pnas.88.18.8154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kanemoto T., Reich R., Royce L., Greatorex D., Adler S. H., Shiraishi N., Martin G. R., Yamada Y., Kleinman H. K. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2279–2283. doi: 10.1073/pnas.87.6.2279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LeBaron R. G., Zimmermann D. R., Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992 May 15;267(14):10003–10010. [PubMed] [Google Scholar]
  13. Lendon C. L., Davies M. J., Born G. V., Richardson P. D. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis. 1991 Mar;87(1):87–90. doi: 10.1016/0021-9150(91)90235-u. [DOI] [PubMed] [Google Scholar]
  14. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995 Jun 1;91(11):2844–2850. doi: 10.1161/01.cir.91.11.2844. [DOI] [PubMed] [Google Scholar]
  15. Marshall B. C., Santana A., Xu Q. P., Petersen M. J., Campbell E. J., Hoidal J. R., Welgus H. G. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest. 1993 Apr;91(4):1792–1799. doi: 10.1172/JCI116390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marti H. P., McNeil L., Thomas G., Davies M., Lovett D. H. Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1. Biochem J. 1992 Aug 1;285(Pt 3):899–905. doi: 10.1042/bj2850899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mauch C., Adelmann-Grill B., Hatamochi A., Krieg T. Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett. 1989 Jul 3;250(2):301–305. doi: 10.1016/0014-5793(89)80743-4. [DOI] [PubMed] [Google Scholar]
  18. Murphy G., Cockett M. I., Ward R. V., Docherty A. J. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J. 1991 Jul 1;277(Pt 1):277–279. doi: 10.1042/bj2770277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nikkari S. T., O'Brien K. D., Ferguson M., Hatsukami T., Welgus H. G., Alpers C. E., Clowes A. W. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995 Sep 15;92(6):1393–1398. doi: 10.1161/01.cir.92.6.1393. [DOI] [PubMed] [Google Scholar]
  20. Noble P. W., Lake F. R., Henson P. M., Riches D. W. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest. 1993 Jun;91(6):2368–2377. doi: 10.1172/JCI116469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Parks W. C., Secrist H., Wu L. C., Mecham R. P. Developmental regulation of tropoelastin isoforms. J Biol Chem. 1988 Mar 25;263(9):4416–4423. [PubMed] [Google Scholar]
  22. Prosser I. W., Stenmark K. R., Suthar M., Crouch E. C., Mecham R. P., Parks W. C. Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol. 1989 Dec;135(6):1073–1088. [PMC free article] [PubMed] [Google Scholar]
  23. Pulford K. A., Rigney E. M., Micklem K. J., Jones M., Stross W. P., Gatter K. C., Mason D. Y. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol. 1989 Apr;42(4):414–421. doi: 10.1136/jcp.42.4.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  25. Rouis M., Nigon F., Lafuma C., Hornebeck W., Chapman M. J. Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetate. Arteriosclerosis. 1990 Mar-Apr;10(2):246–255. doi: 10.1161/01.atv.10.2.246. [DOI] [PubMed] [Google Scholar]
  26. Saarialho-Kere U. K., Crouch E. C., Parks W. C. Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol. 1995 Aug;105(2):190–196. doi: 10.1111/1523-1747.ep12317104. [DOI] [PubMed] [Google Scholar]
  27. Saarialho-Kere U. K., Kovacs S. O., Pentland A. P., Olerud J. E., Welgus H. G., Parks W. C. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest. 1993 Dec;92(6):2858–2866. doi: 10.1172/JCI116906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sanders M. Molecular and cellular concepts in atherosclerosis. Pharmacol Ther. 1994;61(1-2):109–153. doi: 10.1016/0163-7258(94)90060-4. [DOI] [PubMed] [Google Scholar]
  29. Schönherr E., Järveläinen H. T., Sandell L. J., Wight T. N. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 1991 Sep 15;266(26):17640–17647. [PubMed] [Google Scholar]
  30. Sellers A., Woessner J. F., Jr The extraction of a neutral metalloproteinase from the involuting rat uterus, and its action on cartilage proteoglycan. Biochem J. 1980 Sep 1;189(3):521–531. doi: 10.1042/bj1890521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Shapiro S. D., Campbell E. J., Kobayashi D. K., Welgus H. G. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J Clin Invest. 1990 Oct;86(4):1204–1210. doi: 10.1172/JCI114826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shapiro S. D., Kobayashi D. K., Ley T. J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 1993 Nov 15;268(32):23824–23829. [PubMed] [Google Scholar]
  33. Shapiro S. D., Kobayashi D. K., Pentland A. P., Welgus H. G. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J Biol Chem. 1993 Apr 15;268(11):8170–8175. [PubMed] [Google Scholar]
  34. Sires U. I., Griffin G. L., Broekelmann T. J., Mecham R. P., Murphy G., Chung A. E., Welgus H. G., Senior R. M. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem. 1993 Jan 25;268(3):2069–2074. [PubMed] [Google Scholar]
  35. Stary H. C., Chandler A. B., Glagov S., Guyton J. R., Insull W., Jr, Rosenfeld M. E., Schaffer S. A., Schwartz C. J., Wagner W. D., Wissler R. W. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994 May;89(5):2462–2478. doi: 10.1161/01.cir.89.5.2462. [DOI] [PubMed] [Google Scholar]
  36. Wilson C. L., Heppner K. J., Rudolph L. A., Matrisian L. M. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell. 1995 Jul;6(7):851–869. doi: 10.1091/mbc.6.7.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wilson C. L., Matrisian L. M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol. 1996 Feb;28(2):123–136. doi: 10.1016/1357-2725(95)00121-2. [DOI] [PubMed] [Google Scholar]
  38. Yao L. Y., Moody C., Schönherr E., Wight T. N., Sandell L. J. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 1994 Apr;14(3):213–225. doi: 10.1016/0945-053x(94)90185-6. [DOI] [PubMed] [Google Scholar]
  39. van der Wal A. C., Becker A. E., van der Loos C. M., Das P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994 Jan;89(1):36–44. doi: 10.1161/01.cir.89.1.36. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES